Fig. 3.

IFN-γ production after a 7-day expansion of peripheral blood with single TAA peptide antigens that have been shown to be immunodominant (survivin 97–111, the peptides NY-ESO-1 80–94, 89–103 and 157–171); three different conditions: (i) without cytokine (RPMI only), (ii) with a IL-7/IL-2 cytokine cocktail or (iii) with a IL-2/IL-15/IL-21 cytokine cocktail. Data shown after subtraction of the constitutive IFN-γ production